康妇消炎栓联合盆腔炎治疗仪对盆腔炎患者疼痛分值、炎性因子的影响

The Effect of Kangfu Xiaoyan Suppository+Pelvic Inflammatory Treatment Instrument on Pain Score and Inflammatory Factors in Patients with Pelvic Inflammatory Disease

目的:探究康妇消炎栓联合盆腔炎治疗仪对盆腔炎患者疼痛分值、炎性因子的影响。方法:选择新乡医学院第一附属医院2018年5月—2019年12月间收治的68例盆腔炎患者,按照入院顺序尾数的单双数,分为联合组和对照组,每组各34例。对照组给予盐酸左氧氟沙星注射液治疗,联合组在对照组的基础上,给予康妇消炎栓治疗,观察两组患者的治疗效果、治疗前后疼痛分值及炎性因子变化情况。结果:联合组患者经治疗,治疗有效率达到94.12%,对照组患者经治疗,治疗有效率达到70.59%,两组数据对比差异有统计学意义(P<0.05);联合组治疗后的VAS评分为(1.05±0.54)分,低于对照组的(3.81±1.35)分,两组数据相比差异有统计学意义(t=4.135,P<0.05);联合组治疗后的TNF-α、IL-6、IL-8及IL-10水平分别为(83.59±12.52)ng/L、(31.06±8.27)ng/L、(43.68±10.52)ng/L、(128.65±12.33)ng/L,对照组治疗后的TNF-α、IL-6、IL-8及IL-10水平分别为(120.53±14.67)ng/L、(48.96±10.46)ng/L、(61.52±12.75)ng/L、(100.05±10.08)ng/L,两组数据相比差异有统计学意义(t=10.356,12.522,10.589,9.856,P<0.05)。结论:康妇消炎栓联合盆腔炎治疗仪对盆腔炎临床疗效确切,可显著缓解患者痛感,降低血清炎性因子水平,改善临床症状,值得推广。

Objective:To explore the effect of Kangfu Xiaoyan suppository combined with pelvic inflammatory apparatus on pain score and inflammatory factors of patients with pelvic inflammatory disease.Methods:68 patients with pelvic inflammatory disease admitted to the hospital from May 2018 to December 2019 were divided into two groups according to the single and double number of the tail number of admission sequence.The control group was treated with levofloxacin hydrochloride injection,and the combined group was treated with kangfuxiaoyan suppository on the basis of the control group.The therapeutic effect,pain score and inflammatory factor changes of the two groups were observed situation.Results:After treatment,the effective rate of the combined group was 94.12%,and that of the control group was 70.59%,which was statistically significant(P<0.05).After treatment,the VAS score of the combined group was(1.05±0.54),lower than that of the control group(3.81±1.35),which was statistically significant(t=4.135,P<0.05).The levels of TNF-α,IL-σ,IL-8 and IL-10 in the combined group after treatment were(83.59±12.52)ng/L,(31.06±8.27)ng/L,(43.68±10.52)ng/L,(128.65±12.33)ng/L,the levels in the control group were(120.53±14.67)ng/L,(48.96±10.46)ng/L,(61.52±12.75)ng/L,(100.05±10.08)ng/L.Two sets of data were statistically significant(t=10.356,12.522,10.589,9.856,P<0.05).Conclusion:Kangfu Xiaoyan suppository combined with pelvic inflammatory therapy instrument has a definite clinical effect on pelvic inflammatory disease,which can significantly alleviate the pain of patients,reduce the level of serum inflammatory factors,improve clinical symptoms,and is worth popularizing.